MCHI vs XBI
iShares MSCI China ETF vs SPDR S&P Biotech ETF
MCHI—
iShares MSCI China ETF
Broad China equity exposure.
Expense: —Yield: —
XBI—
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: —Yield: —
Side-by-side metrics
| Metric | MCHI | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | State Street |
MCHI top holdings
Holdings data unavailable for MCHI.
XBI top holdings
Holdings data unavailable for XBI.
About MCHI
MCHI (iShares MSCI China ETF) is Broad China equity exposure.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index.